Condition
Pertussis/Whooping Cough
Total Trials
5
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting3
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05847322Not ApplicableRecruitingPrimary
Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
NCT05461131Phase 2CompletedPrimary
Pertussis Challenge Study in Adults Vaccinated With BPZE1
NCT06466629RecruitingPrimary
The Optimal Timing of Vaccination in Pregnancy
NCT05234229CompletedPrimary
Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
NCT04807712RecruitingPrimary
Pediatric Pertussis in Ambulatory Settings
Showing all 5 trials